Abiopharma

Notable Data on Evofems SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting

Ensysce Biosciences Announces Speakers for Major Symposium at PAINWeek 2025

Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025

Johnson & Johnson - New data show TREMFYA®(guselkumab) is the only IL-23 inhibitor proven to significantly inhibit progression of joint structural damage in active psoriatic arthritis

Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma

New data show TREMFYA® (guselkumab) is the only IL-23 inhibitor proven to significantly inhibit progression of joint structural damage in active psoriatic arthritis

SenesTech Announces Bradley Caldwell, Inc. as New U.S. Distributor for Evolve Rodent Fertility Control Products

Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis

McKesson Corporation - McKesson to Host Investor Day on September 23, 2025

Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04